NCT02837198View on ClinicalTrials.gov

Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

March 31, 2018

Conditions
Hyperuricemia
Interventions
DRUG

FYU-981

DRUG

Topiroxostat

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY